November 11, 2014

A Worldwide cancer research grant has been obtained to study the efficacy of the hypoxia-activated bioreductive prodrug TH-302 in combination with radiotherapy on esophageal tumors. We will investigate the therapeutic impact of TH-302 on radiotherapy using a panel of h...

Please reload

Featured Posts

Check out this interview with Maastro Lab group leader Marc Vooijs on their recent work on using lipid lowering drugs to reduce Oxygen consumption in...

Lipid Lowering drugs to improve radiotherapy

May 1, 2017

Please reload

Recent Posts
Please reload

Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Copyright © 2020 | Maastricht Radiation Oncology Lab Maastricht University / MUMC

  • Google Places Social Icon
  • Facebook Social Icon
  • Twitter Social Icon